Roiver Score™ for
CPRXCatalyst Pharmaceutical Inc.
Based on fundamentals through 12/31/2025.
As of December 31, 2025, Catalyst Pharmaceutical Inc. (CPRX) scores 79/100 (Excellent) on the Roiver Score — a transparent quality composite. Its strongest area is cash quality; its weakest is capital structure. The score measures business quality, not timing — it's a signal, not a recommendation.
No black box
Roiver Score is a transparent 0–100 quality composite. Five components, each 0–20: profitability, capital structure, cash quality, valuation, and stability. Inspired by Piotroski's F-Score, Altman's Z-Score, and the Buffett/Munger framework on quality compounders at fair prices. Read the full methodology →
Frequently asked about CPRX
What is CPRX's Roiver Score?
Catalyst Pharmaceutical Inc. scores 79 out of 100 (Excellent) as of December 31, 2025, based on fundamentals.
How is the Roiver Score for CPRX calculated?
It sums five 0–20 components — profitability, capital structure, cash quality, valuation, and stability — into a transparent 0–100 composite. The full methodology is published.
Is CPRX a good quality stock?
On quality, CPRX rates "Excellent" (79/100). Its strongest driver is cash quality and its weakest is capital structure. Quality is one input to a decision, not a buy/sell call.
Embed on your site
Drop this iframe into a Substack, blog post, or notion page. Updates automatically as fundamentals change.
<iframe src="https://roiver.com/embed/score/CPRX" width="640" height="280" frameborder="0" style="border:0;border-radius:16px;overflow:hidden" loading="lazy"></iframe>
Get CPRX's Score in your inbox
A free weekly digest of quality scores and what changed. No account needed.
Educational use only. Roiver Score is a quality signal, not a recommendation.